Form 4: InfuSystem Holdings Executive Carrie Lachance Reports Stock Transactions
SEC Form 4 Filing
Carrie Lachance, President and COO of InfuSystem Holdings, reports acquisition and disposal of common stock and derivative securities.
Summary
- Carrie Lachance, President and COO of InfuSystem Holdings, filed a Form 4 detailing changes in beneficial ownership.
- On May 17, 2025, Lachance acquired 17,727 shares of common stock and disposed of 6,090 shares to cover tax liabilities at a price of $6.15.
- As of May 17, 2025, Lachance directly owns 201,849 shares of common stock.
- On May 16, 2025, Lachance acquired options to buy 74,228 shares and 128,000 shares of common stock at an exercise price of $6, exercisable beginning May 16, 2026, and expiring May 16, 2035.
- On May 16, 2025, Lachance acquired 31,250 restricted stock units (RSUs) that convert into common stock on a one-for-one basis, vesting in three equal annual installments beginning May 16, 2026.
- On May 17, 2025, 17,727 restricted stock units cliff vested.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of executive stock transactions. The acquisition of options and RSUs is mildly positive, while the disposal of shares for tax liabilities is neutral.
Positives
- The acquisition of stock options and restricted stock units by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.
Negatives
- The disposal of 6,090 shares to cover tax liabilities could be perceived negatively, although it's a common practice.
Risks
- Executive stock transactions can sometimes be misinterpreted by the market, leading to short-term price volatility.
- The vesting schedules of the options and RSUs could influence the executive's decisions regarding their tenure with the company.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedules of the options and RSUs suggest a multi-year commitment from the executive.
Industry Context
Executive stock transactions are a common occurrence in publicly traded companies and are routinely disclosed to provide transparency to investors.
Comparison to Industry Standards
- Executive compensation packages, including stock options and RSUs, are standard practice in publicly traded companies to align management's interests with those of shareholders.
- Vesting schedules and exercise prices are typically determined based on industry benchmarks and company performance.
Stakeholder Impact
- Shareholders are informed about changes in beneficial ownership by a key executive.
- Employees may be indirectly affected by the executive's incentives tied to company performance.
Key Dates
| Date | Description |
|---|---|
| 05/16/2025 | Date of stock option and RSU grants. |
| 05/17/2025 | Date of common stock acquisition and disposal, and RSU vesting. |
| 05/16/2026 | Start date for annual vesting of stock options and RSUs. |
| 05/16/2028 | End date for RSU vesting. |
| 05/16/2035 | Expiration date for stock options. |
| 05/20/2025 | Date of Form 4 filing. |
Keywords
Form 4, InfuSystem Holdings, Carrie Lachance, stock options, restricted stock units, beneficial ownership, executive compensation, stock transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.